CERo Therapeutics Holdings, Inc. Announces First Patient Completes Dose-Limiting Toxicity Observation Period with No Reported DLTs in Phase 1 Trial of CER-1236

5 months ago 18
Read Entire Article
  1. Homepage
  2. Finance
  3. CERo Therapeutics Holdings, Inc. Announces First Patient Completes Dose-Limiting Toxicity Observation Period with No Reported DLTs in Phase 1 Trial of CER-1236

Related

Asia shares extend tech rally, yen under pressure

Asia shares extend tech rally, yen under pressure

33 minutes ago 0
China leaves benchmark lending rates unchanged for seventh straight month

China leaves benchmark lending rates unchanged for seventh s...

33 minutes ago 0
Australian state parliament reconvenes to push through stricter gun laws after Bondi mass shooting

Australian state parliament reconvenes to push through stric...

33 minutes ago 0

Trending

1. paige bueckers
2. flight status
3. tennis
4. movies 2025
5. tv shows
6. 28 years later
7. flight
8. dallas stars
9. winter olympics
10. winter olympics 2026

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

11 months ago 638
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

9 months ago 512
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

9 months ago 374
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

9 months ago 331
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

11 months ago 328
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved